Accendra Health (ACH) Cash from Financing Activities (2009 - 2026)

Accendra Health (ACH) has 18 years of Cash from Financing Activities data on file, last reported at $51.1 million in Q1 2026.

• On a quarterly basis, Cash from Financing Activities fell 44.94% year-over-year to $51.1 million in Q1 2026; TTM through Mar 2026 was $146.4 million, a 164.16% increase from a year earlier, with the FY2025 full-year figure at $188.1 million, up 170.28% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at $51.1 million, up from -$117.5 million in the prior quarter.
• Over the last five years, Cash from Financing Activities for ACH reached as high as $1.7 billion in Q1 2022 and fell as low as -$199.6 million in Q3 2024.
• Historically, Cash from Financing Activities has averaged $61.8 million across 5 years, with a median of -$51.2 million in 2023.
• Across the five-year window, Cash from Financing Activities surged 2170.05% in 2022 and tumbled 812.78% in 2023, its largest moves.
• Year by year, Cash from Financing Activities stood at -$63.5 million in 2022, then grew by 19.32% to -$51.2 million in 2023, then grew by 15.85% to -$43.1 million in 2024, then sank by 172.64% to -$117.5 million in 2025, then jumped by 143.48% to $51.1 million in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were $51.1 million in Q1 2026, -$117.5 million in Q4 2025, and $181.1 million in Q3 2025.